• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Beaten-Down Biogen Could Finally Be Reaching an 'Interesting' Level

The shares have been cut in half over the last six months.
By BRUCE KAMICH
Dec 28, 2021 | 10:47 AM EST
Stocks quotes in this article: BIIB

Biogen Inc. (BIIB)  stock has suffered a number of sinking spells over the years. The latest decline started in early June when prices briefly reached the $460 area. Six months later and prices have been cut in half. Is this enough punishment? Would farsighted investors be interested at this price level?

Let's check the charts and indicators.

In the daily bar chart of BIIB, below, we can see that the shares are trading below the declining 50-day moving average line as well as the declining 200-day line. The trading volume looks like it has increased since the middle of October. Heavier volume in a price decline can sometimes mask accumulation. The On-Balance-Volume (OBV) line shows a decline the past six months but so far the early December low has not been broken.

The 12-day price momentum study in the lower panel shows a low in September and a higher low in early December. When compared to the price action of lower lows, the momentum study presents us with a bullish divergence and tells us that the pace of the decline is slowing -- this can be a sign of scale-down buying by farsighted investors.

 
In the weekly Japanese candlestick chart of BIIB, below, we can see that the shares are back to a price area that held back in 2019. Prices are below the declining 40-week moving average line. The 12-week price momentum study is showing improvement from November.
 
The weekly OBV line shows a low in late November.
 
 
In this daily Point and Figure chart BIIB, below, we can see an upside price target in the $272 area.
 
 
Bottom-line strategy: It is early in the "game" but traders might want to put shares of BIIB on their shopping list for 2022.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Biotechnology | Pharmaceuticals | Science

More from Stocks

It's Big-Cap AI Stocks Vs. Everything Else

James "Rev Shark" DePorre
May 30, 2023 4:35 PM EDT

The biggest problem now is that the big-cap names are not acting as leaders.

Beyond Meat and Peloton: Zombie Stocks Can Turn Portfolios Into the Walking Dead

Brad Ginesin
May 30, 2023 3:30 PM EDT

Don't confuse a stock revival masquerading as a living, breathing business revival.

In Case You Missed It: Apple Just Hit a New 52-Week High

Bruce Kamich
May 30, 2023 2:45 PM EDT

Let's not ignore the strength in AAPL.

Bristol-Myers Squibb Breaks a Key Support Area: What's Next?

Bruce Kamich
May 30, 2023 12:50 PM EDT

Here's what the charts and indicators say.

Here's the Truth About Oil No One Saw, as OPEC+ Takes the Stage

Maleeha Bengali
May 30, 2023 12:32 PM EDT

Let's look at what many observers failed to notice about oil, and what could happen when the oil exporting nations -- including Russia -- meet on June 4.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:48 AM EDT CHRIS VERSACE

    Latest AAP Podcast With Portillo's CEO!

    Listen in as we talk with a rising star in the Chi...
  • 03:25 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Don't Just Sit There and 'Hope' for Your Stocks, M...
  • 07:32 AM EDT BOB LANG

    Webinar Thursday After the Close: Option Spread Trading

    Thursday, my good friend and colleague Sam DeMarco...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login